IP Verse

Methods For Treating Hypertrophic Cardiomyopathy

Patent No. EP4370116 (titled "Methods For Treating Hypertrophic Cardiomyopathy") was filed by Cytokinetics on Jul 15, 2022. The application was issued on Jan 15, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HAMM & WITTKOPPOct 14, 2025HAMM & WITTKOPP
SYNTHONOct 14, 2025HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4370116

CYTOKINETICS
Application Number
EP22753953A
Filing Date
Jul 15, 2022
Status
Granted And Under Opposition
Dec 13, 2024
Publication Date
Jan 15, 2025
External Links
Slate, Register , Google Patents